Laura Warner

Newcastle upon Tyne Hospital, Freeman Hospital

Papers

3

Total Citations

62

H-Index

3

About

Laura Warner is a leading surgical oncologist whose research centers on refining transoral robotic surgery (TORS) for head and neck cancers, particularly oropharyngeal squamous cell carcinoma (OPSCC). Her major contributions have reshaped understanding of how surgical margins influence patient outcomes. In a landmark 2022 study (25 citations), she demonstrated that combining TORS with neck dissection alone can achieve favorable oncological results when clear margins are obtained, challenging the routine use of adjuvant therapies. Her subsequent 2023 systematic review and meta-analysis (22 citations) provided definitive evidence linking positive surgical margins to increased local recurrence, establishing a critical benchmark for surgical decision-making. Warner also led the first UK-based large observational series on primary TORS (15 citations), analyzing outcomes from the nation's inaugural TORS practice at a tertiary centre. This work, encompassing all consecutive patients, provided foundational data on the efficacy of TORS with or without adjuvant therapy. With cumulative citations exceeding 60 across her most impactful papers, Warner's research has directly influenced clinical guidelines, reducing overtreatment while improving survival rates. Her work stands as a cornerstone for surgeons seeking to optimize minimally invasive approaches in head and neck oncology.

Research Focus

Key Achievements

3
H-Index
3
Papers
62
Total Citations
21
Avg Citations/Paper
🏆 Most Cited Paper
Transoral robotic surgery and neck dissection alone for head and neck squamous cell carcinoma: Influence of resection margins on oncological outcomes
25 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: Newcastle upon Tyne Hospital, Freeman Hospital

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago